These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 177202)

  • 1. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator.
    Reddy JK; Rao S; Moody DE
    Cancer Res; 1976 Apr; 36(4):1211-7. PubMed ID: 177202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator.
    Reddy JK; Rao MS
    J Natl Cancer Inst; 1977 Dec; 59(6):1645-50. PubMed ID: 200757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
    Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM
    Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of peroxisome proliferation and liver growth-stimulating potential by nondirectly genotoxic compounds in cultured hepatocytes.
    Bieri F; Stäubli W; Kelly S; Waechter F; Bentley P
    Mol Toxicol; 1987-1988 Fall; 1(4):439-44. PubMed ID: 3151502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
    Kraupp-Grasl B; Huber W; Taper H; Schulte-Hermann R
    Cancer Res; 1991 Jan; 51(2):666-71. PubMed ID: 1985784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver.
    Kraupp-Grasl B; Huber W; Putz B; Gerbracht U; Schulte-Hermann R
    Cancer Res; 1990 Jun; 50(12):3701-8. PubMed ID: 1971196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
    Reddy JK
    Am J Pathol; 1974 Apr; 75(1):103-18. PubMed ID: 4825610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response.
    Reddy JK; Azarnoff DL; Svoboda DJ; Prasad JD
    J Cell Biol; 1974 May; 61(2):344-58. PubMed ID: 4208071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
    Numoto S; Furukawa K; Furuya K; Williams GM
    Carcinogenesis; 1984 Dec; 5(12):1603-11. PubMed ID: 6149819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
    Moody DE; Reddy JK
    Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator.
    Bieri F; Bentley P; Waechter F; Stäubli W
    Carcinogenesis; 1984 Aug; 5(8):1033-9. PubMed ID: 6146407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocarcinogenicity of dehydroepiandrosterone in the rat.
    Rao MS; Subbarao V; Yeldandi AV; Reddy JK
    Cancer Res; 1992 May; 52(10):2977-9. PubMed ID: 1316232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin.
    Conway JG; Neptun DA; Garvey LK; Popp JA
    Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of a promoting or sequential syncarcinogenic effect in rat liver by the carcinogenic hypolipidemic drug nafenopin given after N-2-fluorenylacetamide.
    Numoto S; Mori H; Furuya K; Levine WG; Williams GM
    Toxicol Appl Pharmacol; 1985 Jan; 77(1):76-85. PubMed ID: 3966244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic effect in mouse liver induced by a hypolipidemic drug, nafenopin.
    Moody DE; Rao MS; Reddy JK
    Virchows Arch B Cell Pathol; 1977 Apr; 23(4):291-6. PubMed ID: 404752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.